| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.007 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.29 | 0.008 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.009 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |